PDB109 - Cost Effectiveness Evaluation of Canagliflozin in Combination with Metformin and Sulfonylurea in Comparison To Nph Insulin in the Treatment of Type 2 Diabetes Mellitus In Poland

Autor: Szmurlo, D., Drzal, R., Plisko, R., Schubert, A., Skrzekowska-Baran, I.
Zdroj: In Value in Health November 2014 17(7):A351-A351
Databáze: ScienceDirect